Gene · 8744
Papers3,166
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,041 to 1,060 of 3,166
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Immunomodulatory potential of in vivo natural killer T (NKT) activation by NKTT320 in Mauritian-origin cynomolgus macaques. | iScience | 2022 | 35243248 | PubTator, text mining | PubMed |
| The Research Progress in Physiological and Pathological Functions of TRAF4. | Front Oncol | 2022 | 35242717 | PubTator, text mining | PubMed |
| A Novel Prognostic Ferroptosis-Related Long Noncoding RNA Signature in Clear Cell Renal Cell Carcinoma. | J Oncol | 2022 | 35242188 | PubTator, text mining | PubMed |
| OIP5 Is a Novel Prognostic Biomarker in Clear Cell Renal Cell Cancer Correlating With Immune Infiltrates. | Front Immunol | 2022 | 35242130 | PubTator, text mining | PubMed |
| Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies. | J Immunother Cancer | 2022 | 35236742 | PubTator, text mining | PubMed |
| Identification of the Hub Genes and the Signaling Pathways in Human iPSC-Cardiomyocytes Infected by SARS-CoV-2. | Biochem Genet | 2022 | 35235083 | PubTator, text mining | PubMed |
| FAM46C as a Potential Marker for Pan-Cancer Prognosis and Predicting Immunotherapeutic Efficacy. | Front Genet | 2022 | 35222533 | PubTator, text mining | PubMed |
| Feeder Cells at the Interface of Natural Killer Cell Activation, Expansion and Gene Editing. | Front Immunol | 2022 | 35222382 | PubTator, text mining | PubMed |
| Exosomes reveal the dual nature of radiotherapy in tumor immunology. | Cancer Sci | 2022 | 35218675 | PubTator, text mining | PubMed |
| The Landscape of Nanovectors for Modulation in Cancer Immunotherapy. | Pharmaceutics | 2022 | 35214129 | PubTator, text mining | PubMed |
| Alternative splicing and alternative polyadenylation define tumor immune microenvironment and pharmacogenomic landscape in clear cell renal carcinoma. | Mol Ther Nucleic Acids | 2022 | 35211354 | PubTator, text mining | PubMed |
| Tumor-Infiltrating PD-L1+ Neutrophils Induced by GM-CSF Suppress T Cell Function in Laryngeal Squamous Cell Carcinoma and Predict Unfavorable Prognosis. | J Inflamm Res | 2022 | 35210813 | PubTator, text mining | PubMed |
| GIMAP7 as a Potential Predictive Marker for Pan-Cancer Prognosis and Immunotherapy Efficacy. | J Inflamm Res | 2022 | 35210811 | PubTator, text mining | PubMed |
| RFC2: a prognosis biomarker correlated with the immune signature in diffuse lower-grade gliomas. | Sci Rep | 2022 | 35210438 | PubTator, text mining | PubMed |
| The Associations of Single Nucleotide Polymorphisms with Risk and Symptoms of Irritable Bowel Syndrome. | J Pers Med | 2022 | 35207633 | PubTator, text mining | PubMed |
| Scramblases as Regulators of Proteolytic ADAM Function. | Membranes (Basel) | 2022 | 35207106 | PubTator, text mining | PubMed |
| PBK/TOPK Is a Favorable Prognostic Biomarker Correlated with Antitumor Immunity in Colon Cancers. | Biomedicines | 2022 | 35203508 | PubTator, text mining | PubMed |
| Engineering T-cells with chimeric antigen receptors to combat hematological cancers: an update on clinical trials. | Cancer Immunol Immunother | 2022 | 35199207 | PubTator, text mining | PubMed |
| CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism. | Theranostics | 2022 | 35198053 | PubTator, text mining | PubMed |
| Identification and validation a costimulatory molecule gene signature to predict the prognosis and immunotherapy response for hepatocellular carcinoma. | Cancer Cell Int | 2022 | 35193632 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8744/papers?page=53